Journal of Food and Nutrition Research
ISSN (Print): 2333-1119 ISSN (Online): 2333-1240 Website: Editor-in-chief: Prabhat Kumar Mandal
Open Access
Journal Browser
Journal of Food and Nutrition Research. 2017, 5(11), 838-843
DOI: 10.12691/jfnr-5-11-7
Open AccessArticle

Effect of Raw and Cooked Ginger (Zingiber officinale Roscoe) Extracts on Insulin Sensitivity in Normal and High-fat Diet-induced Diabetic Rats

Adeniyi P.O.1, 2, , Sanusi R.A.1 and Obatolu V.A.2

1University of Ibadan, Ibadan, Nigeria

2Institute of Agricultural Research and Training, Ibadan, Obafemi Awolowo University, Nigeria

Pub. Date: November 03, 2017

Cite this paper:
Adeniyi P.O., Sanusi R.A. and Obatolu V.A.. Effect of Raw and Cooked Ginger (Zingiber officinale Roscoe) Extracts on Insulin Sensitivity in Normal and High-fat Diet-induced Diabetic Rats. Journal of Food and Nutrition Research. 2017; 5(11):838-843. doi: 10.12691/jfnr-5-11-7


Few studies have determined the effect of different ginger extracts on insulin sensitivity, very few have explored the effect of raw extract of this spice on this parameter while the effect of cooked ginger extract (the form in which the spice is commonly consumed) is yet to be ascertained. This experimental study was therefore designed to determine the effect of raw and cooked ginger extracts on insulin sensitivity in normal and high-fat diet-induced diabetic rats. Ginger rhizomes were washed, peeled, wet-milled and sieved without adding water to obtain the raw extract. The raw extract was boiled for 1 hour to obtain the cooked extract. Seventy male albino rats of weight range 120-160g were divided into seven groups (n=10) and designated thus: ND2C-non-diabetic control; ND2R-non-diabetic rats given raw ginger extract (2ml/kg body weight); ND2Co- non-diabetic rats given cooked (boiled) ginger extracts; D2C-diabetic control; D2R- diabetic rats given raw ginger extract; D2Co- diabetic rats given cooked ginger extract; and D2D-diabetic rats given metformin (anti-diabetic drug)-200mg/kg body weight. Diabetes was induced in the diabetic groups by feeding the animals with high-fat diet (HFD) for 12 weeks to mimic Type 2 diabetes. Ginger extracts and the drug were administered as a daily oral dose for 4 weeks after diabetes induction. Insulin sensitivity (Insulin Tolerance Test) was determined before and after diabetes induction and at the end of the 4 weeks extracts administration using standard analytical method. Mean data were analyzed using ANOVA at p ≤ 0.05. Baseline Insulin Sensitivity (IS-%/min) in all the groups ranged from 2.2 to 2.4. After 12 weeks feeding, the IS in the three groups fed normal diet ranged from 1.9 to 2.1 while in the four groups fed HFD Insulin Sensitivity ranged from 0.1 to 0.3. Four weeks administration of raw and cooked ginger extracts did not significantly alter IS in normal rats while in diabetic rats raw, cooked ginger extracts and metformin significantly increased IS (%/min) to 2.1, 1.2 and 1.7 respectively relative to control which was 0.1. Insulin Sensitivity was maintained within the normal level in normal rats that were given raw and cooked ginger extracts while the raw extract was more effective than the cooked extract in increasing insulin sensitivity to normal level in diabetic rats. Both raw and cooked ginger extracts improved insulin sensitivity in high-fat diet-induced diabetic rats but the raw extract was more effective, hence, ginger in both forms may be applicable in the management of Type 2 diabetes. Human trial is hereby recommended.

ginger extracts insulin sensitivity high-fat-induced diabetes

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Xu E., Schwah M. and Marette A. (2014). Role of protein tyrosine phosphatase in the modulation of insulin signaling and their implication in the pathogenesis of obesity-linked insulin resistance. Review on Endocrine and Metabolic Disorders; 15(1): 79-97.
[2]  Fukami K., Yamgishi S. and Okuda S. (2014). Role of Advanced Glycation Endproducts-Receptor for dvanced Glycation Endproduct system in cardiovascular disease. Home/Current Pharmaceutical Design; 20(14): 2395-2402.
[3]  Ramachandran A,, Snchalatha C., Latha E., Manoharan M. and Vijay V (1999). Impart of urbanization on the lifestyle on the prevalence of diabetes in Native Asian Indian population. Diabetes Research and Clinical Practice; 44(3): 207-213.
[4]  Harris M.J., Flegal K.M., Cowie C.C., Eberharddt M.S., Goldstein D.E., Little R.R. Weidmeyer H-M and Holt D.D.B. (1998). Prevalence of diabetes impaired fasting glucose and impaired glucose tolerance in U.S. adults: The third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care; 21(4): 518-5.
[5]  Cowie C.C., Rust K.F., Byrd-Holt D.D., Gregg E.W., Ford E.S., Geiss L.S., Banbridge K.E. and Fradkin J.E. (2010). Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care; 33(3): 362-268.
[6]  Pan X-R., Yang W-Y., Li G-W., Liu J. and National Diabetes Prevention and Control Co-operative Group (1997). Prevalence of diabetes and its risk factors in China. Diabetes Care; 20(11): 1664-1669.
[7]  Yang W., Lu J., Weng J., Jia W., Ji L., Xiao J., Shan Z., Liu J., Tian H., Ji Q., Zhu D., Ge J., Lin L., Chen L., Guo X., Zhao Z., Li Q., Zhou Z., Shan G. and He J. (2010). Prevalence of Diabetes among men and women in China. The New England Journal of Medicine; 362: 1090-1101.
[8]  Xu Y., Wang L., He J., Bi Y., Li M., Lu J., Xu M., Li Y., Hu N., Li J., Mi S., Chen C-S., Li G., Mu Y., Zhao J., Kong L., Chen J., Lai S., Wang W., Zhao W. and Ning G. (2013). Prevalence and control of diabetes in Chinese adults. The Journal of the American Medical Association; 310(9): 948-959.
[9]  Rotimi C.N., Cooper R.S., Okosun I.S., Olatubosum S.T., Bella A.F., Wilks R., Bennett F., Cruickshank J.K. and Korrester T.E, (1999). Prevalence of diabetes and impaired glucose tolerance in Nigerians, Jamaicans and U.S. Blacks. Ethnicity and Disease; 9(2): 190-200.
[10]  Cooper R.S., Rotimi C.N., Kaufman J.S., Owoaje E.E., Fraser H., Forrester T., Wilks R., Riste L.K. and Cruickshank J.K. (1997). Prevalence of NIDDM among populations of the African Diaspora. Diabetes Care; 20(3): 343-348.
[11]  Whiting D.R., Guarigata L., Weil C. and Shaw J. (2011). IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research and Clinical Practice; 94(3): 311-321.
[12]  Dabelea D., Hanson R.L., Bennett P.H., Roumain J., Knowler W.C. and Pettitt D.J. (1998). Increasing prevalence of Type 2 diabetes in American Indian children. Diabetologia; 41(8): 904-910.
[13]  Amos A., McCarty D. and Zimmet P. (1997). The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabetic Medicine; 14: S1-S85
[14]  Zimmet P. (2003). The burden of type 2 diabetes, are we doing enough? Diabetes and Metabolism; Vol. 29, Issue 4 part 2: 659-668.
[15]  Wild S., Roglic G., Green A., Sicree R. and King H. (2004). Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care; 27(5): 1047-1053.
[16]  Guariguata L., Whiting D.R., Humbleton I., Beagley J., Linnenkamp U. and Shaw J.E. (2014). Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Research and Clinical Practice; 103(2): 137-149.
[17]  Boden G. and Shulman G.I. (2002). Free fatty acids in obesity and Type 2 diabetes: Defining their role in the development of insulin resistance and beta cell dysfunction.European Journal of Clinical Invesigation; 32: 14-23.
[18]  Kraegen E.W., Cooney G.T., Ye J. and Thompson A.L. (2001). Triglycerides, fatty acids and insulin resistance, hyperinsulinemia. Experimental and Clinical Endocrinology and Diabetes; 109: 516-526.
[19]  Steppan C.M. and Lazar M.A. (2004). The current biology of resistin. Journal of Internal Medicine; 255: 439-447.
[20]  Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., Mori Y., Ide T., Murakami K. and Tsuboyama-Kasaoka N. (2001). The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine; 7: 941-946.
[21]  Park S-Y., Cho Y-R., Kim H-J., Higashimori T., Danton C., Lee M-K., Dey A., Rothermel B., Kim Y-B., Kalinowski A., Russel K.S. and Kim J.K. (2005). Unravelling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice. Diabetes; 54: 3530-3540.
[22]  White M.F. (1998). The IRS-1 signaling system: a network of docking proteins that mediate insulin and cytokines action. Recent Progress in Hormone Research; 53: 119-138.
[23]  Le Roith D. and Zick Y. (2001). Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care; 24: 588-97.
[24]  Goldstein B.J., Bittner-Kowalczyk A., White M.F. and Harbeck M. (2000). Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein tyrosine phosphatase 1B, possible facilitation by the formation of a ternary complex with the grb2 adaptor protein. Journal of Biological Chemistry; 275: 4283-4289.
[25]  Ojewole J.A.O (2006). Analgesic, Antiinflammatory and Hypoglycemic effects of ethanol extract of Zingiber officinale (Roscoe) rhizomes in mice and rats. Phytotherapy Research: 20: 764-772.
[26]  Al-Amin Z.M., Thomson M., Al-Qattan K.K., Peltonen-Shalaby R. and Ali M. (2006). Antidiabetic and hypolipidemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. British Journal of Nutrition; 96(4): 660-666.
[27]  Akhani S.P., Vishwakarma S.L and Goyal R.K. (2005). Antidiabetic activity of Zingiber officinale Roscoe in streptozotocin-induced non-insulin dependent diabetic rats. Indian Journal of Pharmaceutical Science; 65(5): 553-557.
[28]  Elshater A.A., Salman M.M.A. and Moussa M.M.A. (2009). Effect of Ginger extract consumption on levels of blood glucose, lipid profile and kidney functions in alloxan-induced diabetic rats. Egyptian Academic Journal of Biological Sciences; 2(1): 153-162.
[29]  Martinello F., Soares S.M. and Franco J.J. (2006). Hypolipidemic and antioxidant sctivates from Tamarindus indica pulp fruit extract in hypercholesterolemic hamsters. Food and Chemical Toxicology; 44(6): 810-818.
[30]  Buettner R., Parhofer K.G., Woenckhaus M., Wrede C.E., Kunz-Schughart L.A., Scholmerich J. and Bollheimer L.C. (2006). Defining high-fat diet rat models: metabolic and molecular effects of different fat types. Journal of Molecular Endocrinology; 36: 485-501.
[31]  Okita K., Iwahashi H., Kozawa J., Okauchi Y., Funahashi T., Imagawa A. and Shimomura I. (2013). Usefulness of the insulin tolerance test in patients with Type 2 diabetes receiving insulin therapy. Journal of Diabetes Investigation; 5(3): 30-312.
[32]  Croze M.L., Geleon A. and Soulage C.O. (2015). Abnormalities in myo-inositol metabolism associated with type 2 diabetes in mice fed a high-fat diet: benefits of a dietary myo-inositol supplementation. British Journal of Nutrition; 113: 1862-1875.
[33]  Pereira M.P., Buzelle S.L., Batistela E., Doneda D.L., De Franca S.A., dos Sandos M.P., Andrade C.M.B., Ganofalo M.A.R. and Kawashita N.H. (2014). High glucose uptake in growing rats adapted to a low-protein high-carbohydrate diet determines low fasting glycemia even with high hepatic gluconeogenesis. Canadian Journal of Physiology and Pharmacology; 92(6): 460-466.
[34]  Li Y., Tran V.H., Kota B.P., Nammi S., Duke C.C. and Roufogalis B.D. (2014). Preventive effect of Zingiber offinale on insulin resistance in a high-fat high-carbohydrate diet-fed rat model and its mechanism of action. Basic Clinical Pharmacology and Toxicology; 115(2): 209-215.
[35]  Arablou T., Aryaeian N., Valizadeh M., Shariffi F., Hosseini A. and Djalali M. (2014). The effect of ginger consumption on glycemic status, lipid profile and some inflammatory markers in patients with Type 2 diabetes mellitus. InternationalJournal of Food Sciences and Nutrition; 65(4): 515-520.
[36]  Mozaffari-Khosravi H., Talaei B., Jalali B-A., Najarzadeh A. and Mozayan M.R. (2014). The effect of ginger powder supplementation on insulin resistance and glycemic indices in patients with Type 2 diabetes: A randomized double-blind placebo-controlled trial. Complementary Therapies in Medicine; 22(1): 9-16.
[37]  Mahluji S., Attari V.E., Mabassori M., Payahoo L., Ostadrahimi A. and Golzari S.E.J. (2013). Effect of ginger (Zingiber officinale) on plasma glucose level, HbA1c and insulin sensitivity in type 2 diabetic patients. International Journal of Food Sciences and Nutrition; 64(6): 682-686.
[38]  Iranloye B.O., Arikawe A.P., Rotimi G and Sobade A.O. (2011). Anti diabetic and antioxidant effects of Zingiber officinale on alloxan-induced and insulin resistant diabetic male rats. Nigerian Journal of Physiological Sciences; 26(1): 89-96.